Elder Pharmaceuticals Limited, a under liquidation public limited company, was established on 02 April 1983 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: L24239MH1983PLC029714. Registered under ROC Roc Mumbai. it is listed. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹20.54 Cr.
Its leadership includes Kader Mohamed Davawala (Additional Director), Alok Jagdish Saxena (Managing Director), Abdul Khader Mohammed Ravani (Additional Director). Past directors included Peter Charles Bibby, Shrikrishna Pandurang Date, Saleem Iqbal Shervani. It holds ₹338.10 Cr open charges and ₹3,335.92 Cr settled loans. Its latest AGM occurred on 30 December 2013, with the balance sheet filed on 30 June 2013. It is based at Elder House Plot No C9Dalia Industrial Estate Off Veera Desai Road Andheri W India, Mumbai, Maharashtra, 400058.
L24239MH1983PLC029714
029714
02 April 1983
₹30.00 Cr
₹20.54 Cr
Roc Mumbai
Listed
Under Liquidation
Explore comprehensive insights into Elder Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kader Mohamed Davawala | Additional Director | 25 Jan 2016 | Current |
| Alok Jagdish Saxena | Managing Director | 29 Aug 2002 | Current |
| Abdul Khader Mohammed Ravani | Additional Director | 25 Jan 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Apr 2009 | Past |
| Pramod Abcsdd | Company Secretary | 25 Apr 2014 | Past |
| Pramod Abcsdd | Director | 11 Dec 2014 | Past |
| Pramod Abcsdd | Managing Director | 10 Oct 2013 | Past |
| Pramod Abcsdd | Additional Director | 01 Jan 2016 | Past |
| Pramod Abcsdd | Director | 05 Jun 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Elder Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Elder Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹3,381,000,000.00
₹33,359,158,008.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Oct 2014 | Dcb Bank Limited | ₹16.00 Cr | Open |
| 30 Jul 2014 | Bank Of India | ₹35.00 Cr | Open |
| 19 Nov 2012 | Axis Trustee Services Limited | ₹70.00 Cr | Open |
| 28 Jun 2011 | Axis Trustee Services Limited | ₹73.00 Cr | Open |
| 21 Mar 2011 | Axis Trustee Services Limited | ₹118.80 Cr | Open |
Explore comprehensive loan charge details -
Elder Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Elder Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elder Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kader Mohamed Davawala was appointed as a Additional Director was appointed as a Additional Director on 25 Jan 2016 & has been associated with this company since 9 years 10 months . was documented.
Abdul Khader Mohammed Ravani was appointed as a Additional Director was appointed as a Additional Director on 25 Jan 2016 & has been associated with this company since 9 years 10 months . was recorded as a recent event.
A charge with Dcb Bank Limited of Rs. 16.00 Cr registered on 10 Oct 2014 with Charge ID 10531139 was modified on 15 Oct 2014. was recorded as a recent event.
Progress on A charge with Dcb Bank Limited amounted to Rs. 16.00 Cr with Charge ID 10531139 was registered on 10 Oct 2014. was documented.
The activity A charge registered on 26 Jun 2014 via Charge ID 10504846 with Dbs Bank Ltd was fully satisfied on 19 Aug 2014. was completed.
Progress on A charge with Bank Of India amounted to Rs. 35.00 Cr with Charge ID 10514198 was registered on 30 Jul 2014. was documented.
The CIN of Elder Pharmaceuticals Limited is L24239MH1983PLC029714.
Elder Pharmaceuticals Limited is headquartered at Elder House Plot No C9Dalia Industrial Estate Off Veera Desai Road Andheri W India, Mumbai, Maharashtra, 400058.
Elder Pharmaceuticals Limited was incorporated on 02 April 1983.
The current directors of Elder Pharmaceuticals Limited are
The primary industry of Elder Pharmaceuticals Limited is Pharma.
Elder Pharmaceuticals Limited is listed.
The authorized capital of Elder Pharmaceuticals Limited is ₹30.00 Cr, and the paid-up capital is ₹20.54 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX